부산대학교 도서관

Barnkob MB; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK. mike.bogetofte.barnkob@rsyd.dk.; Centre for Cellular Immunotherapy of Haematological Cancer Odense (CITCO), Department of Clinical Immunology, Odense University Hospital, University of Southern Denmark, Odense, Denmark. mike.bogetofte.barnkob@rsyd.dk.; Michaels YS; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Paul Albrechtsen Research Institute, CancerCare Manitoba, 675 Mcdermot Ave, Winnipeg, MB, R3E 0V9, Canada.; Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Bannatyne Ave, Winnipeg, MB, R3E 3N4, Canada.; André V; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Macklin PS; Nuffield Department of Medicine, University of Oxford, Nuffield Department of Medicine Research Building, Roosevelt Drive, Oxford, OX3 7FZ, UK.; Gileadi U; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Valvo S; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK.; Rei M; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Kulicke C; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, OR, US.; Chen JL; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Jain V; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK.; Woodcock VK; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Colin-York H; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Hadjinicolaou AV; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Division of Gastroenterology & Hepatology, Department of Medicine, Cambridge University Hospitals, University of Cambridge, Cambridge, England.; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, England.; Kong Y; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK.; Mayya V; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK.; Mazet JM; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK.; Mead GJ; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK.; Bull JA; Wolfson Centre for Mathematical Biology, Mathematical Institute, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK.; Rijal P; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Pugh CW; Nuffield Department of Medicine, University of Oxford, Nuffield Department of Medicine Research Building, Roosevelt Drive, Oxford, OX3 7FZ, UK.; Townsend AR; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Gérard A; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK.; Olsen LR; Department of Health Technology, Technical University of Denmark, Ørsteds Plads, Building 345C, 2800 Kgs, Lyngby, Denmark.; Fritzsche M; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK.; Fulga TA; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Dustin ML; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK.; Jones EY; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. yvonne@strubi.ox.ac.uk.; Cerundolo V; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE

Barnkob MB; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK. mike.bogetofte.barnkob@rsyd.dk.; Centre for Cellular Immunotherapy of Haematological Cancer Odense (CITCO), Department of Clinical Immunology, Odense University Hospital, University of Southern Denmark, Odense, Denmark. mike.bogetofte.barnkob@rsyd.dk.; Michaels YS; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Paul Albrechtsen Research Institute, CancerCare Manitoba, 675 Mcdermot Ave, Winnipeg, MB, R3E 0V9, Canada.; Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Bannatyne Ave, Winnipeg, MB, R3E 3N4, Canada.; André V; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Macklin PS; Nuffield Department of Medicine, University of Oxford, Nuffield Department of Medicine Research Building, Roosevelt Drive, Oxford, OX3 7FZ, UK.; Gileadi U; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Valvo S; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK.; Rei M; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Kulicke C; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, OR, US.; Chen JL; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Jain V; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK.; Woodcock VK; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Colin-York H; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Hadjinicolaou AV; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Division of Gastroenterology & Hepatology, Department of Medicine, Cambridge University Hospitals, University of Cambridge, Cambridge, England.; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, England.; Kong Y; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK.; Mayya V; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK.; Mazet JM; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK.; Mead GJ; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK.; Bull JA; Wolfson Centre for Mathematical Biology, Mathematical Institute, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK.; Rijal P; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Pugh CW; Nuffield Department of Medicine, University of Oxford, Nuffield Department of Medicine Research Building, Roosevelt Drive, Oxford, OX3 7FZ, UK.; Townsend AR; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Gérard A; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK.; Olsen LR; Department of Health Technology, Technical University of Denmark, Ørsteds Plads, Building 345C, 2800 Kgs, Lyngby, Denmark.; Fritzsche M; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK.; Fulga TA; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Dustin ML; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK.; Jones EY; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. yvonne@strubi.ox.ac.uk.; Cerundolo V; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Bryant, Richard J; Hobbs, Catherine; Richardson, Charlotte; Fox, Sebastian; Joseph, Johnson; Verrill, Clare; Woodcock, Victoria K; Sullivan, Mark E; Protheroe, Andrew S

Journal of Clinical Urology. Jul2019, Vol. 12 Issue 4, p274-279. 6p.

Woodcock VK; Department of Oncology Churchill Hospital, University of Oxford Oxford UK.; MRC Human Immunology Unit MRC Weatherall Institute of Molecular Medicine Oxford UK.; Chen JL; MRC Human Immunology Unit MRC Weatherall Institute of Molecular Medicine Oxford UK.; Purshouse K; Department of Oncology Churchill Hospital, University of Oxford Oxford UK.; Butcher C; Oncology Clinical Trials Office, Department of Oncology University of Oxford Oxford UK.; Collins L; Oncology Clinical Trials Office, Department of Oncology University of Oxford Oxford UK.; Haddon C; Department of Oncology Churchill Hospital, University of Oxford Oxford UK.; Verrall G; Department of Urology Churchill Hospital Oxford UK.; Elhussein L; Centre for Statistics in Medicine University of Oxford Oxford UK.; Roberts C; Centre for Statistics in Medicine University of Oxford Oxford UK.; Tarlton A; MRC Human Immunology Unit MRC Weatherall Institute of Molecular Medicine Oxford UK.; Rei M; MRC Human Immunology Unit MRC Weatherall Institute of Molecular Medicine Oxford UK.; Napolitani G; MRC Human Immunology Unit MRC Weatherall Institute of Molecular Medicine Oxford UK.; Salio M; MRC Human Immunology Unit MRC Weatherall Institute of Molecular Medicine Oxford UK.; Middleton MR; Department of Oncology Churchill Hospital, University of Oxford Oxford UK.; National Institute for Health Research Oxford Biomedical Research Centre Oxford UK.; Cerundolo V; MRC Human Immunology Unit MRC Weatherall Institute of Molecular Medicine Oxford UK.; Crew J; Department of Urology Churchill Hospital Oxford UK.; Protheroe AS; Department of Oncology Churchill Hospital, University of Oxford Oxford UK.

Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101764975 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-4526 (Electronic) Linking ISSN: 26884526 NLM ISO Abbreviation: BJUI Compass Subsets: PubMed not MEDLINE

Woodcock, Victoria K; Clive, Sally; Wilson, Richard H; Coyle, Vicky M; Stratford, Michael R L; Folkes, Lisa K; Eastell, Richard; Barton, Claire; Jones, Paul; Kazmi-Stokes, Shamim; Turner, Helen; Halford, Sarah; Harris, Adrian L; Middleton, Mark R

British Journal of Cancer. 3/20/2018, Vol. 118 Issue 6, p770-776. 7p. 1 Diagram, 3 Charts, 2 Graphs.

Taylor CA; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.; Watson RA; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.; Tong O; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.; Ye W; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.; Nassiri I; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.; Gilchrist JJ; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Paediatrics, University of Oxford, Oxford, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.; de Los Aires AV; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.; Sharma PK; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.; Koturan S; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.; Cooper RA; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.; Woodcock VK; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.; Jungkurth E; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.; Shine B; Department of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.; Coupe N; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.; Payne MJ; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.; Church DN; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.; Naranbhai V; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Center for the AIDS Programme of Research in South Africa, Durban, South Africa.; Groha S; Department of Medical Oncology, Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Emery P; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.; National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Mankia K; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.; National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Middleton MR; Department of Oncology, University of Oxford, Oxford, UK.; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Gusev A; Department of Medical Oncology, Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; Fairfax BP; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. benjamin.fairfax@oncology.ox.ac.uk.; Department of Oncology, University of Oxford, Oxford, UK. benjamin.fairfax@oncology.ox.ac.uk.; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK. benjamin.fairfax@oncology.ox.ac.uk.; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. benjamin.fairfax@oncology.ox.ac.uk.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Middleton MR; Department of Oncology, Medical Sciences Division, University of Oxford, Headington, Oxford, United Kingdom. mark.middleton@oncology.ox.ac.uk.; McAlpine C; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Woodcock VK; Department of Oncology, Medical Sciences Division, University of Oxford, Headington, Oxford, United Kingdom.; Corrie P; Cambridge University Hospitals, NHS Foundation Trust, Cambridge, United Kingdom.; Infante JR; Janssen, Philadelphia, Pennsylvania.; Steven NM; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; Evans TRJ; Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.; Anthoney A; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.; Shoushtari AN; Memorial Sloan Kettering Cancer Center, New York, New York.; Hamid O; Immunooncology, The Angeles Clinic and Research Institute, Los Angeles, California.; Gupta A; Department of Oncology, Medical Sciences Division, University of Oxford, Headington, Oxford, United Kingdom.; Vardeu A; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Leach E; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Naidoo R; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Stanhope S; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Lewis S; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Hurst J; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; O'Kelly I; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Sznol M; Yale Cancer Center, Yale School of Medicine, Yale, Connecticut.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Fayed HE; Department of Medicine, Oxford University Hospitals, Banbury, UK.; Woodcock VK; Grayez J

Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X (Electronic) Linking ISSN: 1757790X NLM ISO Abbreviation: BMJ Case Rep Subsets: MEDLINE